Nuwellis (NUWE) Enterprise Value Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.48% |
| Dec 31, 2025 | 40.41% |
| Sep 30, 2025 | 29.64% |
| Jun 30, 2025 | 10.67% |
| Mar 31, 2025 | 14.72% |
| Dec 31, 2024 | -31.84% |
| Sep 30, 2024 | 12.10% |
| Jun 30, 2024 | 32.69% |
| Mar 31, 2024 | 34.36% |
| Dec 31, 2023 | 7.06% |
| Sep 30, 2023 | 9.72% |
| Jun 30, 2023 | -4.93% |
| Mar 31, 2023 | -2.85% |
| Dec 31, 2022 | -3.26% |
| Sep 30, 2022 | -36.83% |
| Jun 30, 2022 | -22.52% |
| Mar 31, 2022 | -63.32% |
| Dec 31, 2021 | -78.84% |
| Sep 30, 2021 | -104.65% |
| Jun 30, 2021 | -14.76% |
| Mar 31, 2021 | -11.11% |
| Dec 31, 2020 | 8.98% |
| Sep 30, 2020 | 8.45% |
| Jun 30, 2020 | 25.21% |
| Mar 31, 2020 | 31.29% |
| Dec 31, 2019 | 47.24% |
| Sep 30, 2019 | 36.99% |
| Jun 30, 2019 | 29.37% |
| Mar 31, 2019 | 24.69% |
| Dec 31, 2018 | 36.75% |
| Sep 30, 2018 | 32.76% |
| Jun 30, 2018 | 20.13% |
| Mar 31, 2018 | 0.86% |
| Dec 31, 2017 | -1.86% |
| Sep 30, 2017 | 32.13% |
| Jun 30, 2017 | -25.69% |
| Mar 31, 2017 | 15.40% |
| Dec 31, 2016 | 27.41% |
| Sep 30, 2016 | 40.19% |
| Jun 30, 2016 | -13.27% |
| Mar 31, 2016 | -11.33% |